Get In Touch

Hemofiltration is a renal replacement therapy, generally used in intensive care settings. The procedure is carried out for acute kidney injury, multiple organ dysfunction, and other renal disorders. The process involves filtration of patient’s blood. The patient’s blood passes through filtration circuit, a set of tubing, through a semipermeable membrane (filter). The solutes & other impurities are separated from the blood by convection. The replacement fluid is added to the blood and it is returned to the patient’s body via a machine (a set of tubing). A positive hydrolyte pressure drives solutes and water from blood compartment to the filtrate compartment. The hemofiltration process takes several hours to complete, during which the blood is pumped on continuous basis through the membrane filter and back to the patient. The components that are small enough to pass through the filter pores are removed from the blood.

Rising geriatric population, continuous advancements in the technologies associated with hemofiltration procedures, and high prevalence of acute kidney injury are the major factors expected to drive the hemofiltration systems market during the forecast period. However, high procedural cost, the complexity in the process, and lack of trained and qualified personnel in developing economies are likely to hamper the growth of the hemofiltration systems market from 2016 to 2024.

The global hemofiltration systems market has been segmented based on modality and end-user. In terms of end-user, the global hemofiltration systems market has been divided into hospitals, outpatient settings, and others. The hospitals segment dominated the global hemofiltration systems market in 2015, attributed to the availability of well-equipped facilities in the intensive care units, positive reimbursement policies, and rising number of patients with acute kidney injury and renal dysfunction. The segment is expected to continue to dominate the hemofiltration systems market during the forecast period driven by technological advancements in the procedures. Based on modality, the global hemofiltration system market has been segmented into continuous hemofiltration and intermittent hemofiltration. Intermittent hemofiltration is a short duration process, normally takes three to four hours to complete, and the replacement fluid is prepared online from the dialysis solution. However, continuous hemofiltration procedure requires eight to 12 hours for completion, as the substitution fluid used in this process (CHF) is commercially prepared, and sterile to avoid regulatory issues related to on-line creation of substitution fluid from dialysis solution. The continuous hemofiltration systems segment held the largest share of the hemofiltration systems market in 2015 owing to high adoption rate among patients. The segment is anticipated to lead the market during the forecast period, due to improving health care infrastructure and rising incidence of acute renal injuries and failures.

Geographically, the global hemofiltration systems market is broadly classified into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest market share in terms of revenue in 2015, owing to the favorable reimbursement policies in hospitals, technological advancements in the renal replacement procedures, and high adoption rate among the population for healthcare facilities. The region is expected to continue to dominate the global market during the forecast period. This is attributed to the presence of key players in the market. Asia Pacific is likely to be the fastest growing market in terms of CAGR, due to the growing geriatric population, rising focus of multinational industries on the emerging economies, and attempts made by government and private organizations to improve health care infrastructure facilities.

Major players in the global hemofiltration systems market are Asahi Kasei Corporation, Baxter International, Infomed SA, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Nikkiso Co., Ltd, Nipro, Medica S.p.A., NxStage Medical, Inc., and Bellco among others. Companies focus on the geographic expansion, acquisition, and partnerships as key business strategies.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Hemofiltration Systems Market

Pre Book